○Mai Tsuchiya1, Kishin Koh1, Hiroyuki Ishiura2, Haruo Shimazaki3, Takeshi Nakamura4, Kohei Suzuyama5, Hideo Hara5, Makio Takahashi6, Shoji Tsuji7,8, Yoshihisa Takiyama1, Japan Spastic Paraplegia Research Consortium9 (1.Department of Neurology, Graduate school of Medical Sciences, University of Yamanashi, Japan, 2.Department of Neurology, The University of Tokyo, 3.Faculty of Health & Medical Care, Saitama Medical University, 4.Department of Neurology,Kyoto Takeda Hospital, 5.Division of Neurology, Department of Internal Medicine, Saga University Faculty of Medicine, 6.Department of Neurology, Osaka Red Cross Hospital, 7.Department of Molecular Neurology, Graduate School of Medicine, The University of Tokyo, 8.Institute of Medical Genomics, International University of Health and Welfare, 9.Japan Spastic Paraplegia Research Consortium)
Session information
Oral Session
[O-36] Oral Session 36 Cerebellar ataxia and Myelopathy2
Fri. May 21, 2021 9:45 AM - 11:15 AM Room 13 (ICC Kyoto 1F Room C-2)
Chair:Matsuura Tohru(Division of Neurology, Department of Medicine, Jichi Medical University)
○Akira Takekoshi1, Akio Kimura1, Nobuaki Yoshikura1, Katsuya Nakamura2, Kunihiro Yoshida3, Takayoshi Shimohata1 (1.Department of Neurology, Gifu University Graduate School of Medicine, Japan, 2.Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3.JA Nagano Koseiren Kakeyu-Misayama Rehabilitation Center Kakeyu Hospital)
○Takanori Hata1, Kishin Koh1, Yuta Ichinose1, Mai Tsutiya1, Takamura Nagasaka1, Kazumasa Shindo1, Hiroyuki Ishiura2, Shoji Tsuji2,3, Yoshihisa Takiyama1, Japan Spastic Paraplegia Research Consortium4 (1.Department of Neurology, The University of Yamanashi, Japan, 2.Department of Neurology, The University of Tokyo, 3.Institute of Medical Genomics, International University of Health and Welfare, 4.Japan Spastic Paraplegia Research Consortium)
○Haruo Shimazaki1, Tomoko Ogawa2, Kishin Ko3, Yoichi Yamamoto4, Jun Tsugawa5, Chieko Murakami6, Masayuki Honda7, Katsuro Kurokawa8, Yasutaka Iwanaga9, Mitsuharu Ueda10, Yoshihisa Takiyama3, JASPAC11 (1.Faculty of Health & Medical Care, Saitama Medical University/Department of Neurology, Saitama Medical University Hospital, Japan, 2.Department of Neurology, International University of Health and Welfare Hospital, 3.Department of Neurology, University of Yamanashi, 4.Department of Neurology, Osaka University, 5.Department of Neurology, Fukuoka University, 6.Department of Neurology, Hirosaki University, 7.Department of Neurology, Tokyo Metropolitan Neurological Hospital, 8.Department of Neurology, Yamagata National Hospital, 9.Department of Neurology, Kyushu University, 10.Department of Neurology, Kumamoto University, 11.Japan Spastic Paraplegia Research Consortium)
○Ryusuke Takaki1,2, Haitian Nan2, Takanori Hata2, Kishin Koh2, Yoshihisa Takiyama2 (1.Department of Neurology, Iida Hospital, Japan, 2.Department of Neurology, Graduate School of Medical Sciences, University of Yamanashi, Japan)
○Yuta Ichinose1, Kishin Koh1, Hiroyuki Ishiura2, Tatsushi Toda2, Dai Matsuse3, Heisuke Mizukami4, Yoshihisa Yamano4, Shoji Tsuji5,6, Yoshihisa Takiyama1 (1.Department of Neurology, University of Yamanashi, Japan, 2.Department of Neurology, The University of Tokyo, 3.Department of Neurology, Kyushu University, 4.Department of Neurology, St. Marianna University School of Medicine, 5.Department of Molecular Neurology, Graduate School of Medicine, The University of Tokyo, 6.Institute of Medical Genomics, International University of Health and Welfare)